New treatment approaches for superficial and invasive bladder cancer - doses for chemoprevention trials

Author： Grossman H.B.   Debruyne F.M.J.   Akaza H.   Aso Y.   Kagawa S.   Kakehi Y.   van der Meijden A.P.M.   Ratliff T.L.  

Publisher： Elsevier

ISSN： 1078-1439

Source： Urologic Oncology: Seminars and Original Investigations, Vol.4, Iss.4, 1998-07, pp. : 183-187

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Controlled Trials and Chemoprevention of Cancer

By Heinonen Olli P.  

Acta Oncologica, Vol. 37, Iss. 3, 1998-07 ,pp. : 231-234

Informa Healthcare

Access to resources Recommend Favorite

Neopterin as a monitoring parameter for treatment with BCG in superficial bladder cancer

By Mack D.   Gomahr A.   Herold M.   Frick J.  

European Journal of Cancer, Vol. 31, Iss. 6, 1995-06 ,pp. : 1025-1026

Elsevier

Access to resources Recommend Favorite

The novel bladder preservation therapy BOAI-CDDP-radiation (OMC-regimen): A new treatment option for invasive bladder cancer patients with lymph node metastasis

By                                

International Journal of Oncology, Vol. 44, Iss. 6, 2014-01 ,pp. : 1895-1903

Spandidos Publications

Access to resources Recommend Favorite

Cathepsin D serum and urine concentration in superficial and invasive transitional bladder cancer as determined by surface plasmon resonance imaging

By        

Oncology Letters, Vol. 8, Iss. 3, 2014-01 ,pp. : 1323-1327

Spandidos Publications

Access to resources Recommend Favorite

Selenium and Colon Cancer - From Chemoprevention to New Treatment Modality

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 6, 2008-08 ,pp. : 598-602

Bentham Science Publishers

Access to resources Recommend Favorite